AMRX logo

Amneal Pharmaceuticals, Inc. (AMRX) Revenue

Annual revenue:

$2.79B+$400.35M(+16.73%)
December 31, 2024

Summary

  • As of today (August 16, 2025), AMRX annual revenue is $2.79 billion, with the most recent change of +$400.35 million (+16.73%) on December 31, 2024.
  • During the last 3 years, AMRX annual revenue has risen by +$700.29 million (+33.45%).
  • AMRX annual revenue is now at all-time high.

Performance

AMRX Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMRXincome statement metrics

Quarterly revenue:

$724.51M+$29.09M(+4.18%)
June 30, 2025

Summary

  • As of today (August 16, 2025), AMRX quarterly revenue is $724.51 million, with the most recent change of +$29.09 million (+4.18%) on June 30, 2025.
  • Over the past year, AMRX quarterly revenue has increased by +$22.73 million (+3.24%).
  • AMRX quarterly revenue is now -0.82% below its all-time high of $730.52 million, reached on December 31, 2024.

Performance

AMRX Quarterly revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMRXincome statement metrics

TTM revenue:

$2.85B+$22.73M(+0.80%)
June 30, 2025

Summary

  • As of today (August 16, 2025), AMRX TTM revenue is $2.85 billion, with the most recent change of +$22.73 million (+0.80%) on June 30, 2025.
  • Over the past year, AMRX TTM revenue has increased by +$254.92 million (+9.81%).
  • AMRX TTM revenue is now at all-time high.

Performance

AMRX TTM revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMRXincome statement metrics

AMRX Revenue Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+16.7%+3.2%+9.8%
3 y3 years+33.5%+29.5%+34.4%
5 y5 years+71.8%+55.9%+64.1%

AMRX Revenue Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+33.5%-0.8%+32.8%at high+34.4%
5 y5-yearat high+71.8%-0.8%+55.9%at high+64.1%
alltimeall timeat high>+9999.0%-0.8%>+9999.0%at high>+9999.0%

AMRX Revenue History

DateAnnualQuarterlyTTM
Jun 2025
-
$724.51M(+4.2%)
$2.85B(+0.8%)
Mar 2025
-
$695.42M(-4.8%)
$2.83B(+1.3%)
Dec 2024
$2.79B(+16.7%)
$730.52M(+4.0%)
$2.79B(+4.2%)
Sep 2024
-
$702.47M(+0.1%)
$2.68B(+3.2%)
Jun 2024
-
$701.78M(+6.5%)
$2.60B(+4.1%)
Mar 2024
-
$659.19M(+6.8%)
$2.50B(+4.2%)
Dec 2023
$2.39B(+8.2%)
$616.98M(-0.5%)
$2.39B(+0.3%)
Sep 2023
-
$620.04M(+3.5%)
$2.39B(+3.2%)
Jun 2023
-
$599.05M(+7.4%)
$2.31B(+1.7%)
Mar 2023
-
$557.54M(-8.6%)
$2.27B(+2.7%)
Dec 2022
$2.21B(+5.7%)
$609.76M(+11.8%)
$2.21B(+3.4%)
Sep 2022
-
$545.56M(-2.5%)
$2.14B(+0.8%)
Jun 2022
-
$559.36M(+12.4%)
$2.12B(+1.2%)
Mar 2022
-
$497.63M(-7.3%)
$2.10B(+0.2%)
Dec 2021
$2.09B(+5.1%)
$536.90M(+1.6%)
$2.09B(+1.3%)
Sep 2021
-
$528.59M(-1.2%)
$2.07B(+0.5%)
Jun 2021
-
$535.08M(+8.5%)
$2.06B(+3.5%)
Mar 2021
-
$493.11M(-3.3%)
$1.99B(-0.3%)
Dec 2020
$1.99B(+22.5%)
$510.03M(-1.8%)
$1.99B(+6.0%)
Sep 2020
-
$519.29M(+11.8%)
$1.88B(+8.1%)
Jun 2020
-
$464.66M(-6.8%)
$1.74B(+3.6%)
Mar 2020
-
$498.53M(+25.5%)
$1.68B(+3.2%)
Dec 2019
$1.63B(-2.2%)
$397.33M(+5.0%)
$1.63B(-5.8%)
Sep 2019
-
$378.28M(-6.5%)
$1.73B(-5.4%)
Jun 2019
-
$404.64M(-9.3%)
$1.82B(-0.5%)
Mar 2019
-
$446.12M(-10.3%)
$1.83B(+10.3%)
Dec 2018
$1.66B(+60.9%)
$497.53M(+4.4%)
$1.66B(+14.0%)
Sep 2018
-
$476.49M(+15.2%)
$1.46B(+17.9%)
Jun 2018
-
$413.79M(+50.4%)
$1.24B(+14.2%)
Mar 2018
-
$275.19M(-6.2%)
$1.08B(+34.1%)
Dec 2017
$1.03B(+25.4%)
$293.37M(+15.2%)
$807.97M(+13.3%)
Sep 2017
-
$254.73M(-2.0%)
$713.03M(+3.9%)
Jun 2017
-
$259.87M(>+9900.0%)
$686.20M(+14.6%)
Mar 2017
-
$0.00(-100.0%)
$598.92M(-27.4%)
Dec 2016
$824.43M(-4.2%)
-
-
Dec 2016
-
$198.42M(-12.9%)
$824.43M(-9.2%)
Sep 2016
-
$227.91M(+32.1%)
$908.10M(+0.8%)
Jun 2016
-
$172.59M(-23.5%)
$901.29M(-4.4%)
Mar 2016
-
$225.51M(-20.1%)
$942.88M(+9.6%)
Dec 2015
$860.47M(+44.4%)
$282.09M(+27.6%)
$860.47M(+21.3%)
Sep 2015
-
$221.10M(+3.2%)
$709.59M(+9.8%)
Jun 2015
-
$214.18M(+49.7%)
$646.49M(+4.2%)
Mar 2015
-
$143.10M(+9.1%)
$620.43M(+4.1%)
Dec 2014
$596.05M(+16.5%)
$131.21M(-17.0%)
$596.05M(+5.4%)
Sep 2014
-
$158.00M(-16.0%)
$565.58M(+4.7%)
Jun 2014
-
$188.12M(+58.5%)
$540.22M(+12.1%)
Mar 2014
-
$118.72M(+17.8%)
$481.73M(-5.8%)
Dec 2013
$511.50M(-12.1%)
$100.74M(-24.0%)
$511.50M(-7.3%)
Sep 2013
-
$132.64M(+2.3%)
$551.84M(-2.3%)
Jun 2013
-
$129.63M(-12.7%)
$564.78M(-6.1%)
Mar 2013
-
$148.49M(+5.3%)
$601.61M(+3.4%)
Dec 2012
$581.69M
$141.08M(-3.1%)
$581.69M(-2.9%)
Sep 2012
-
$145.59M(-12.5%)
$599.17M(+4.5%)
DateAnnualQuarterlyTTM
Jun 2012
-
$166.46M(+29.5%)
$573.44M(+7.6%)
Mar 2012
-
$128.57M(-18.9%)
$532.84M(+3.9%)
Dec 2011
$512.92M(-41.7%)
$158.56M(+32.3%)
$512.92M(+13.1%)
Sep 2011
-
$119.85M(-4.8%)
$453.46M(-28.9%)
Jun 2011
-
$125.86M(+15.8%)
$637.61M(-4.1%)
Mar 2011
-
$108.65M(+9.6%)
$664.83M(-24.4%)
Dec 2010
$879.51M(+145.4%)
$99.10M(-67.4%)
$879.51M(-8.1%)
Sep 2010
-
$303.99M(+98.6%)
$956.54M(+33.3%)
Jun 2010
-
$153.08M(-52.7%)
$717.50M(+15.2%)
Mar 2010
-
$323.33M(+83.6%)
$622.83M(+73.8%)
Dec 2009
$358.41M(+70.6%)
$176.13M(+171.2%)
$358.41M(+57.9%)
Sep 2009
-
$64.95M(+11.2%)
$226.97M(+14.2%)
Jun 2009
-
$58.42M(-0.8%)
$198.80M(-9.2%)
Mar 2009
-
$58.91M(+31.8%)
$219.05M(+4.3%)
Dec 2008
$210.07M(-23.3%)
$44.70M(+21.5%)
$210.07M(-9.8%)
Sep 2008
-
$36.77M(-53.3%)
$232.84M(-24.8%)
Jun 2008
-
$78.67M(+57.6%)
$309.49M(+6.7%)
Mar 2008
-
$49.93M(-26.0%)
$290.02M(+5.9%)
Dec 2007
$273.75M(+102.4%)
$67.47M(-40.5%)
$273.75M(+6.1%)
Sep 2007
-
$113.42M(+91.6%)
$257.94M(+46.5%)
Jun 2007
-
$59.20M(+75.9%)
$176.06M(+20.1%)
Mar 2007
-
$33.66M(-34.8%)
$146.60M(+8.4%)
Dec 2006
$135.25M(+20.3%)
$51.65M(+63.7%)
$135.25M(+61.8%)
Sep 2006
-
$31.55M(+6.1%)
$83.59M(+60.6%)
Jun 2006
-
$29.74M(+33.4%)
$52.05M(+133.4%)
Mar 2006
-
$22.30M(-27.4%)
$22.30M(-80.2%)
Dec 2005
$112.40M(+91.1%)
-
-
Sep 2004
-
$30.70M(+0.5%)
$112.64M(+14.4%)
Jun 2004
-
$30.56M(-11.5%)
$98.44M(+20.1%)
Mar 2004
-
$34.55M(+105.3%)
$81.94M(+39.3%)
Dec 2003
$58.82M(+139.9%)
$16.83M(+2.0%)
$58.82M(+16.7%)
Sep 2003
-
$16.50M(+17.3%)
$50.39M(+21.6%)
Jun 2003
-
$14.07M(+23.1%)
$41.43M(+27.4%)
Mar 2003
-
$11.43M(+36.0%)
$32.51M(+32.6%)
Dec 2002
$24.52M(+271.9%)
$8.40M(+11.4%)
$24.52M(+35.1%)
Sep 2002
-
$7.54M(+46.5%)
$18.14M(+48.0%)
Jun 2002
-
$5.14M(+49.9%)
$12.26M(+48.6%)
Mar 2002
-
$3.43M(+69.5%)
$8.25M(+25.2%)
Dec 2001
$6.59M(-35.2%)
$2.02M(+22.1%)
$6.59M(+12.4%)
Sep 2001
-
$1.66M(+46.0%)
$5.87M(-16.0%)
Jun 2001
-
$1.14M(-35.9%)
$6.99M(-20.2%)
Mar 2001
-
$1.77M(+36.3%)
$8.76M(-7.9%)
Dec 2000
$10.17M(+720.2%)
$1.30M(-53.2%)
$9.50M(+15.8%)
Sep 2000
-
$2.78M(-4.5%)
$8.20M(+0.5%)
Jun 2000
-
$2.91M(+15.5%)
$8.16M(+6.8%)
Mar 2000
-
$2.52M(>+9900.0%)
$7.65M(+9.9%)
Dec 1999
$1.24M(-71.8%)
$0.00(-100.0%)
$6.96M(-15.3%)
Sep 1999
-
$2.74M(+14.6%)
$8.21M(+22.5%)
Jun 1999
-
$2.39M(+30.8%)
$6.70M(+25.7%)
Mar 1999
-
$1.83M(+45.8%)
$5.33M(+21.1%)
Dec 1998
$4.40M
$1.25M(+1.9%)
$4.40M(+39.8%)
Sep 1998
-
$1.23M(+20.6%)
$3.15M(+64.1%)
Jun 1998
-
$1.02M(+13.6%)
$1.92M(+113.6%)
Mar 1998
-
$898.00K
$898.00K

FAQ

  • What is Amneal Pharmaceuticals, Inc. annual revenue?
  • What is the all time high annual revenue for Amneal Pharmaceuticals, Inc.?
  • What is Amneal Pharmaceuticals, Inc. annual revenue year-on-year change?
  • What is Amneal Pharmaceuticals, Inc. quarterly revenue?
  • What is the all time high quarterly revenue for Amneal Pharmaceuticals, Inc.?
  • What is Amneal Pharmaceuticals, Inc. quarterly revenue year-on-year change?
  • What is Amneal Pharmaceuticals, Inc. TTM revenue?
  • What is the all time high TTM revenue for Amneal Pharmaceuticals, Inc.?
  • What is Amneal Pharmaceuticals, Inc. TTM revenue year-on-year change?

What is Amneal Pharmaceuticals, Inc. annual revenue?

The current annual revenue of AMRX is $2.79B

What is the all time high annual revenue for Amneal Pharmaceuticals, Inc.?

Amneal Pharmaceuticals, Inc. all-time high annual revenue is $2.79B

What is Amneal Pharmaceuticals, Inc. annual revenue year-on-year change?

Over the past year, AMRX annual revenue has changed by +$400.35M (+16.73%)

What is Amneal Pharmaceuticals, Inc. quarterly revenue?

The current quarterly revenue of AMRX is $724.51M

What is the all time high quarterly revenue for Amneal Pharmaceuticals, Inc.?

Amneal Pharmaceuticals, Inc. all-time high quarterly revenue is $730.52M

What is Amneal Pharmaceuticals, Inc. quarterly revenue year-on-year change?

Over the past year, AMRX quarterly revenue has changed by +$22.73M (+3.24%)

What is Amneal Pharmaceuticals, Inc. TTM revenue?

The current TTM revenue of AMRX is $2.85B

What is the all time high TTM revenue for Amneal Pharmaceuticals, Inc.?

Amneal Pharmaceuticals, Inc. all-time high TTM revenue is $2.85B

What is Amneal Pharmaceuticals, Inc. TTM revenue year-on-year change?

Over the past year, AMRX TTM revenue has changed by +$254.92M (+9.81%)
On this page